Handelsbanken Fonder AB Buys 14,756 Shares of Revvity Inc. $RVTY

Handelsbanken Fonder AB lifted its stake in Revvity Inc. (NYSE:RVTY) by 39.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,116 shares of the company’s stock after acquiring an additional 14,756 shares during the period. Handelsbanken Fonder AB’s holdings in Revvity were worth $5,042,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. ProShare Advisors LLC increased its position in Revvity by 2.0% during the 4th quarter. ProShare Advisors LLC now owns 32,536 shares of the company’s stock valued at $3,148,000 after buying an additional 637 shares in the last quarter. HighTower Advisors LLC increased its position in Revvity by 2.6% during the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after buying an additional 129 shares in the last quarter. North Dakota State Investment Board acquired a new position in Revvity during the 4th quarter valued at about $391,000. Allworth Financial LP increased its position in Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after buying an additional 104 shares in the last quarter. Finally, Nicholas Company Inc. increased its position in Revvity by 8.1% during the 4th quarter. Nicholas Company Inc. now owns 143,330 shares of the company’s stock valued at $13,867,000 after buying an additional 10,730 shares in the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Stock Up 1.6%

Revvity stock opened at $96.93 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The business’s 50-day simple moving average is $90.69 and its two-hundred day simple moving average is $96.96. The company has a market cap of $10.81 billion, a PE ratio of 46.38, a PEG ratio of 2.05 and a beta of 1.05. Revvity Inc. has a fifty-two week low of $81.22 and a fifty-two week high of $118.30.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. The business had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts anticipate that Revvity Inc. will post 5.33 EPS for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is presently 13.40%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on RVTY shares. Jefferies Financial Group upped their target price on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Evercore upped their target price on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research report on Tuesday, February 3rd. Barclays upped their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. The Goldman Sachs Group reduced their target price on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Finally, Weiss Ratings lowered Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.